Interleukin 7 generates antitumor cytotoxic t lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy

Journal of Experimental Medicine

Volumn 174, Issue 6, 1991, Pages 1511-1515

  Jicha, Douglas L ^a   Mulé, James J ^a   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 7;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CYTOTOXIC T LYMPHOCYTE; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; LUNG SARCOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; FEMALE; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; INTERLEUKIN-7; METHYLCHOLANTHRENE; MICE; MICE, INBRED C57BL; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0025827591     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.174.6.1511     Document Type: Article

References (18)

1. Yang, J.C., and S.A. Rosenberg. 1991. Adoptive cellular therapy: preclinical studies. In Biologic Therapy of Cancer. V.T. DeVita, S. Heilman, and S. A. Rosenberg, editors. J.B. Lippincott Company, Philadelphia, PA. pg. 197.
2. Widmer, M.B., and K.H. Grabstein. 1987. Regulation of cytolytic T-lymphocy te generation by B-cell stimulatory factor. Nature (Lond.). 326:795.
3. Mulé, J.J., C.A. Smith, and S.A. Rosenberg. 1987. Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells. J. Exp Med. 166:792.
4. Garman, R.D., and D.H. Raulet. 1987. Characterization of a novel murine T-cell-activating factor. J. Immunol. 138:1121.
5. Uyttenhove, C., P.G. Coulie, and J.V. Snick. 1988. T cell growth and differentiation induced by interleukin-HP-l/IL-6, the murine hybridoma/plasmacytoma growth factor. J. Exp Med. 167:1417.
6. Namen, A.E., A.E. Schmierer, C.J. March, R.W. Overell, L.S. Park, D.L. Urdal, and D.Y. Mochizuki. 1988. B cell precursor growth-promoting factor: purification and characterization of a factor active on lymphocyte precursors.J. Exp Med. 167:988.
7. Namen, A.E., S. Lupton, K. Hjerrild, J. Wignal, D.Y. Mochizuki, A. Schmierer, B. Mosley, C.J. March, D. Urdal, S. Gillis, D. Cosman, and R.G. Goodman. 1988. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature (Lond.). 333:571.
8. Goodwin, R.G., S. Lupton, A. Schmierer, K.J. Hjerrild, R. Jerzy, W. Clevenger, S. Gillis, D. Cosman, and A.E. Namen. 1989. Human interleukin-7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl. Acad. Sci. USA. 86:302.
9. Watson, J.D., P.J. Morrissey, A.E. Namen, P.J. Conlon, and M.R Widner. 1989. Effect of IL7 on the growth of fetal thymocytes in culture. J. Immunol. 143:1215.
10. Conlon, P.J., P.J. Morrissey, R.P. Nordan, K.H. Grabstein, K.S. Prickett, S.G. Reed, R. Goodwin, D. Cosman, and A.E. Namen. 1989. Murine thymocytes proliferate in direct response to interleukin-7. Blood. 74:1368.
11. Ozazaki, H., M. Ito, T. Sudo, M. Hattori, S. Kano, Y. Kat-sura, and N. Minato. 1989. IL-7 promotes thymocyte proliferation and maintains immunocompetent thymocytes bearing or T-cell receptors in vitro: Synergism with IL-2. J. Immunol. 143:2917.
12. Chazen, G.D., G.M. Pereira, G. LeGros, S. Gillis, and E. Shevach. 1989. Interleukin 7 is a T-cell growth factor. Proc Natl. Acad. Sci. USA. 86:5923.
13. Grabstein, K.H., A.E. Namen, K. Shanebeck, R.F. Voice, S.G. Reed, and M.B. Widmer. 1990. Regulation of T-cell proliferation by IL-7. J. Immunol. 144:3015.
14. Morrissey, P.J., R.G. Goodwin, R.P. Nordan, D. Anderson, K.H. Grabstein, D. Cosman, J. Sims, S. Lupton, R Acres, S.G. Reed, D. Mochizuki, J. Eisenman, P.J. Conlan, and A.E. Namen. 1989. Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J. Exp Med. 169:707.
15. Bertagnolli, M., and S. Herrmann. 1990. IL-7 supports the generation of cytotoxic T lymphocytes from thymocytes: Multiple lymphokines required for proliferation and cytotoxicity. J. Immunol. 145:1706.
16. Shu, S., T. Chou, and S.A. Rosenberg. 1987. Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy. J. Immunol. 139:295.
17. Barth, R.J., S.N. Bock, J.J. Mulé, and S.A. Rosenberg. 1990. Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes. J. Immunol. 139:295.
18. Rosenberg, S.A., P. Spiess, and R. Lafreniere. 1986. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science (Wash. DC). 133:1318.